Biologically Self-Assembled Tumor Cell-Derived Cancer Nanovaccines as an All-in-One Platform for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Biologically Self-Assembled Tumor Cell-Derived Cancer Nanovaccines as an All-in-One Platform for Cancer Immunotherapy

Published:2024-02-15 Issue:8 Volume:18 Page:6702-6717
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Liang Kaifan¹²,Sun Yinzhe¹²,Xie Laozhi¹²,Liu Yipu¹²,You Yang¹²,Xu Jianpei¹²,Ma Fenfen¹²,Huang Yukun³,Song Qingxiang³,Xiao Wenze⁴,Huang Jianming⁵,Gao Xiaoling³^ORCID,Chen Jun¹²^ORCID

Affiliation:

1. Department of Pharmaceutics, School of Pharmacy & Shanghai Pudong Hospital, Fudan University, 201203 Shanghai, China

2. Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, 201203 Shanghai, China

3. Department of Pharmacology and Chemical Biology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China

4. Department of Rheumatology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 201399, Shanghai, China

5. School of Pharmacy, Fudan University, 201203 Shanghai, China

Funder

Fudan University

Shanghai Municipal Health and Family Planning Commission

Shanghai Municipal Education Commission

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Science and Technology Development Fund Of Shanghai Pudong New Area

Publisher

American Chemical Society (ACS)

Link